..great pick up 50% today!, made money.., gl..thx ...
Recent ZNTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 12:01:56 PM
- Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer • GlobeNewswire Inc. • 04/09/2026 12:00:00 PM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/01/2026 09:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:46:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:24:44 PM
- Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates • GlobeNewswire Inc. • 03/26/2026 08:05:00 PM
- Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 • GlobeNewswire Inc. • 03/17/2026 08:30:00 PM
- Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 02:10:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2026 01:27:50 AM
- Zentalis Pharmaceuticals to Participate in Upcoming Investor Conference • GlobeNewswire Inc. • 02/03/2026 09:05:00 PM
- Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 • PR Newswire (Canada) • 01/12/2026 03:35:00 PM
- Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 • PR Newswire (US) • 01/12/2026 03:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2026 01:36:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2026 01:34:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 10:18:32 PM
- Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026 • GlobeNewswire Inc. • 01/06/2026 01:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/30/2025 09:10:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 10:01:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:11:02 PM
- Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress • GlobeNewswire Inc. • 11/10/2025 09:05:00 PM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/03/2025 10:25:00 PM
